Kyowa Kirin, Inc.- U.S. Tech Stack
Specialty pharma with oncology, immunotherapy, and CNS focus across North America
Kyowa Kirin's North America operation is mid-scale (501–1,000) with R&D, manufacturing, and commercial units across Princeton NJ, Toronto, and La Jolla CA. The hiring mix is manufacturing-heavy (8 roles) with active scaling in healthcare, ops, and quality — reflecting a company in active facility build-out and product launch phase. Recent projects (rocatinlimab US launch, equipment commissioning, process validation, GMP readiness) and acute pain around greenfield site startup and regulatory compliance map to a growing manufacturing footprint. Tech stack is enterprise-heavy (Veeva Vault, LIMS, Dynamics 365, cloud platforms) with new adoption of security scanning (SAST/DAST), signaling tighter DevSecOps discipline.
Tech Stack 19 technologies
What Kyowa Kirin, Inc.- U.S. Is Building
◆Challenges
- Compliance with pharmaceutical regulatory requirements
- Greenfield site startup
- Ensuring gmp readiness
- Maintaining gxp compliance
- Environmental permit management
- Patient identification challenge
- Access to therapy
- Cost efficiency
- Savings opportunities
- Audit readiness
▲Active Projects
- Process validation
- Automation implementation
- Annual risk-based audit plan
- Equipment commissioning
- Us launch of rocatinlimab
- Secure architecture patterns
- Continuous improvement projects for the kkna manufacturing facility
- Managed care strategy development
- Comprehensive database of study specifics
- Tracker optimization initiative
Hiring Activity
Department
Seniority
Notable leadership hires: Sales Director, Medical Director, Oncology Regional Business Director
